LD Locati, L Licitra, L Agate,
SHI Ou, A Boucher… - Cancer, 2014 - Wiley Online Library
BACKGROUND In a previous phase 2 trial, axitinib was active and well tolerated in patients
with advanced thyroid cancer. In this second phase 2 trial, the efficacy and safety of axitinib …